Ditch the Delays: Set SMART Goals and Conquer Your Promotional Review Process

 

In the fast-paced marketing world, setting clear, measurable goals for the promotional review process is not just beneficial; it’s essential for efficiency, team morale, and ultimately, success. As businesses navigate the complexities of promotional content approval processes, the beginning of a new year marks a perfect time for reflection and goal setting.

How can marketing teams effectively set, measure, and adjust their promotional review goals to enhance workflow and outcomes?

Amend and Progress,” a podcast by Vodori features Annalise Ludtke, the Senior Manager of Marketing and Communications at Vodori and Anne Swearingen, the CEO at 6 Tangerines Consulting. Their conversation sheds light on actionable strategies and best practices that can transform the promotional review process. The two discuss:

  • The importance of setting holistic goals for average review times and aiming for improvements.
  • The need to delve deeper into the review process by examining content types and reviewer groups to identify areas for efficiency gains.
  • The role of organizational goals in shaping and guiding the promotional review process.

Anne Swearingen brings a wealth of experience to the discussion. As an independent consultant and the CEO of 6 Tangerines Consulting, she has a solid background in improving organizational processes and setting achievable goals. Her insights are backed by her extensive industry experience and a deep understanding of the challenges and opportunities within promotional review teams.

Recent Episodes

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…